antiandrogens - Health Topics
Second-generation antiandrogens (AAs) ― abiraterone, apalutamide, darolutamide, and enzalutamide ― are a cornerstone of modern prostate cancer treatment, improving outcomes and survival. However, they ... Renal & Urology News: Second-Generation Antiandrogens Up Risk for Cognitive, Functional Toxic Effects The increasing number of indications for second-generation antiandrogens may result in a large group of men at risk for toxic effects, according to investigators.
Understanding the Context
Second-generation antiandrogens have ... Science Daily: Prostate cancer: Androgen receptor activates different genes when bound to antiandrogens Renal & Urology News: Second-Generation Antiandrogens Linked to Falls, Cognitive Toxicity in Prostate Cancer Patients Source: Getty Images Prostate cancer patients treated with second-generation antiandrogens may have an increased risk of falls, fatigue, and cognitive toxicity. Prostate cancer patients treated with ... Nature: Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?
Image Gallery
Key Insights
Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer? ascopubs.org: Real-life data of antiandrogens (AA) use in metastatic androgen receptor positive triple negative breast cancer (AR+ TNBC): The ATOVAT retrospective French cohort. Real-life data of antiandrogens (AA) use in metastatic androgen receptor positive triple negative breast cancer (AR+ TNBC): The ATOVAT retrospective French cohort. Nature: Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model